On the other hand, TM6SF2 activity is essential for normal very low-density lipoprotein (VLDL) secretion; however, hepatic expression of this gene is significantly low in NAFLD patients [15]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.